A detailed history of Citigroup Inc transactions in Nutri Band Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,260 shares of NTRB stock, worth $6,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,260
Holding current value
$6,930
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$5.98 - $10.72 $7,534 - $13,507
1,260 New
1,260 $8,000
Q1 2025

May 12, 2025

BUY
$4.07 - $9.39 $41,550 - $95,862
10,209 New
10,209 $62,000
Q2 2022

Aug 10, 2022

SELL
$2.81 - $5.69 $7,868 - $15,932
-2,800 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$3.3 - $9.43 $9,240 - $26,404
2,800 New
2,800 $12,000

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $42.9M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.